We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Malignant Melanoma

    Reference work entry 2024
  2. Prospective associations of leucocyte subtypes and obesity with the risk of develo** cutaneous malignant melanoma in the UK Biobank cohort

    Background

    Obesity is associated with chronic low-grade inflammation, which is linked to cancer development. Abdominal obesity (a body mass index,...

    Sofia Christakoudi, Konstantinos K. Tsilidis, Elio Riboli in BMC Cancer
    Article Open access 23 May 2024
  3. Exploring of miR-155-5p, miR-181b-5p, and miR-454-3p Expressions in Circulating Cell-Free RNA: Insights from Peripheral Blood of Uveal Malignant Melanoma Patients

    The identification of novel non-invasive biomarkers is imperative for the early diagnosis and monitoring of malignant melanoma. The objective of this...

    Hassani Masoumeh, Doğan Tunay, ... Yazıcı Hülya in Biochemical Genetics
    Article Open access 24 June 2024
  4. A Japanese case of familial malignant melanoma with germline CDK4 variant incidentally diagnosed by cancer genome profiling

    Familial malignant melanoma (FMM) is a hereditary tumor that is quite rare in Japan; to date, the germline CDK4 variant has scarcely been reported...

    Yoshimi Kiyozumi, Keisuke Goto, ... Hiroyuki Matsubayashi in Journal of Human Genetics
    Article 11 January 2023
  5. Tumor cell-induced platelet aggregation accelerates hematogenous metastasis of malignant melanoma by triggering macrophage recruitment

    Background

    Tumor cell-induced platelet aggregation (TCIPA) is not only a recognized mechanism for paraneoplastic thrombocytosis but also a potential...

    Yuyi Chen, Jie Zhou, ... Ganlin Zhang in Journal of Experimental & Clinical Cancer Research
    Article Open access 23 October 2023
  6. Therapeutic applications of local injection of hsa-miR-634 into canine spontaneous malignant melanoma tumors

    Malignant melanoma (MM) is one of the most common tumors in both dogs and humans. As canine MM (CMM) and human MM (HMM) have similar clinical...

    Ryutaro Yoshikawa, Jun Inoue, ... Johji Inazawa in Cancer Gene Therapy
    Article 08 August 2023
  7. Melanoma risk, tumour stage, and melanoma-specific mortality in individuals with diabetes: a systematic review and meta-analysis

    Background

    Cancer has become the leading diabetes-related cause of death in high-income countries, and more knowledge is needed to clarify the impact...

    Jens Ejrnæs Tønder, Marie Louise Bønnelykke-Behrndtz, ... Martin Sollie in BMC Cancer
    Article Open access 07 July 2024
  8. Immune checkpoint inhibitor (ICI) genes and aging in malignant melanoma patients: a clinicogenomic TCGA study

    Background

    Cancer diagnoses and deaths among the elderly (65 +) are expected to increase significantly over the next decade. Immune checkpoint...

    Mohammed Safi, Chenxing **, ... Jiwei Liu in BMC Cancer
    Article Open access 13 September 2022
  9. High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types

    Background

    A regional skin cancer prevention program in Eastern Finland revealed a relatively high age-standardized mortality due to malignant...

    Ville Suhonen, Jaana Rummukainen, ... Ilkka T. Harvima in BMC Cancer
    Article Open access 29 October 2021
  10. IRF4-activated TEX41 promotes the malignant behaviors of melanoma cells by targeting miR-103a-3p/C1QB axis

    Background

    Malignant melanoma is an aggressive skin cancer and a tumor of melanocytic origin. Recent studies have suggested that long non-coding RNAs...

    Yingna Zheng, Wu Zhou, ... Ying Cen in BMC Cancer
    Article Open access 16 December 2021
  11. Immunotherapy for Cutaneous Melanoma

    Melanoma is the most aggressive skin cancer whose incidence is increasing in western countries. Among novel treatments, immunotherapy has shown...
    Alireza Soleymanitabar, Mahsa Keshavarz-Fathi, ... Nima Rezaei in Handbook of Cancer and Immunology
    Living reference work entry 2023
  12. Dormancy of cutaneous melanoma

    Many cancer-related deaths including melanoma result from metastases that develop months or years after the initial cancer therapy. Even the most...

    Kathrin Singvogel, Birgit Schittek in Cancer Cell International
    Article Open access 28 February 2024
  13. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st–3rd, 2022—Naples, Italy)

    Outcomes for patients with melanoma have improved over the past decade with the clinical development and approval of immunotherapies targeting immune...

    Paolo A. Ascierto, Sanjiv S. Agarwala, ... Magdalena Thurin in Journal of Translational Medicine
    Article Open access 28 July 2023
  14. ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/ β-catenin signaling pathway

    Background

    Malignant melanoma (MM) is highly metastatic and has the highest mortality rate in patients with skin cancer. The ERBB3 binding protein 1...

    Yanqiu Bao, **gshu Cui, ... Lan Liu in Cancer Cell International
    Article Open access 29 January 2022
  15. Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion

    Background

    The mitogen-activated protein kinase (MAPK) signaling pathway is frequently hyperactivated in malignant melanoma and its inhibition has...

    Corinna Kosnopfel, Simone Wendlinger, ... Birgit Schittek in Journal of Experimental & Clinical Cancer Research
    Article Open access 19 July 2023
  16. The role of mitochondria in the resistance of melanoma to PD-1 inhibitors

    Malignant melanoma is one of the most common tumours and has the highest mortality rate of all types of skin cancers worldwide. Traditional and novel...

    Fei Du, Lu-han Yang, ... Fang Wang in Journal of Translational Medicine
    Article Open access 23 May 2023
  17. Association between physical activity, grip strength and sedentary behaviour with incidence of malignant melanoma: results from the UK Biobank

    Background

    Physical activity has been positively related to malignant melanoma. However, that association may be confounded by ultraviolet radiation...

    Andrea Weber, Michael F. Leitzmann, ... Sebastian E. Baumeister in British Journal of Cancer
    Article Open access 31 May 2021
  18. The Immunogenetics of Melanoma

    MelanomaMelanoma is a relatively common and deadly type of skin cancer that originates from melanocytes. Cutaneous malignant melanoma results from...
    Chapter 2022
  19. Correlation between hemoglobin and the risk of common malignant tumors: a 1999–2020 retrospective analysis and causal association analysis

    Background

    The role of hemoglobin (HGB) in common malignant tumors remains unclear.

    Methods

    A retrospective analysis was conducted to identify the...

    Guo-Sheng Li, Tao Huang, ... Hua-Fu Zhou in BMC Cancer
    Article Open access 21 June 2024
Did you find what you were looking for? Share feedback.